Mesothelioma Prognosis and Survival Rates: Women and Extended Pleurectomy Decortication

Mesothelioma Prognosis and Survival Rates: Women and Extended Pleurectomy Decortication

Malignant pleural mesothelioma is a fast-spreading cancer tied to asbestos. Sadly, patients on standard treatments survive just 12–18 months. However, recent studies show better outcomes for some, especially women. They receive ePD surgery, part of a combined treatment. Now, a new article examines mesothelioma patient outcomes. It looks at the factors impacting survival and the benefits of specific treatments. Understanding Pleural Mesothelioma and the Pleural Space Pleural mesothelioma is a cancer in the pleura, the thin membrane around the lungs and chest. It’s mainly caused by asbestos exposure, from work or the environment. This cancer affects the pleural space, crucial for lung movement during breathing. A tumor or pleural effusion, excess fluid, can harm breathing and worsen mesothelioma symptoms. Clinical…

Safer Surgery for Mesothelioma Patients: Promising Strategies Revealed in Recent Study
|

Safer Surgery for Mesothelioma Patients: Promising Strategies Revealed in Recent Study

Researchers from the University of Pennsylvania tested four strategies to make mesothelioma surgery safer for patients. Enhancing Mesothelioma Surgery Safety Mesothelioma is a rare type of cancer caused by asbestos. It is found in the lining of organs in the body. The most common locations for mesothelioma are in the lungs and abdomen. In this study, the patients had mesothelioma in the lungs. The treatment plan for mesothelioma usually combines multiple therapies. The conventional treatment strategy is surgery, chemotherapy, and radiation. One type of surgery for mesothelioma is called pleurectomy and decortication (P/D). This surgery is performed by a thoracic surgeon. The surgeon first removes as much of the diseased lung membrane as possible (pleurectomy). The second step is to…